doc.ai


doc.ai is developing A.I. technologies to collect structured and real-world medical data to create engaging products, accelerate medical research and transform approaches to care. Their poly-omics data pipeline handles all forms of medical data to make it ready for analysis and model building. The company's primary consumer offering is a medical research companion app for personal-omics collection and digital health trials where participants can earn financial rewards. Additionally, they license A.I. modules and create products for a portfolio of clients, including payors, pharma, providers and patient organizations.

Industries

artificial-intelligence
clinical-trials
health-care
machine-learning
medical
software

Nr. of Employees

medium (51-250)

doc.ai

Palo Alto, California, United States, North America


Patents

Hash-based efficient comparison of sequencing results

US-11984198-B2

View Details

Artificial intelligence-based generation of anthropomorphic signatures and use thereof

US-11755709-B2

View Details

Bin-specific and hash-based efficient comparison of sequencing results

US-11664089-B2

View Details

Ordinal position-specific and hash-based efficient comparison of sequencing results

US-11551784-B2

View Details

Systems and methods for generating and using anthropomorphic signatures to authenticate users

US-11321447-B2

View Details

Artificial intelligence-based generation of anthropomorphic signatures and use thereof

US-11256801-B2

View Details
View All Patents

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.